Vaccine manufacturing and safety in the spotlight - This year's flu vaccine shortage may spur new manufacturing, regulatory and market approaches to vaccine production

被引：0

|

作者：

Wechsler, J

机构：

来源：

BIOPHARM INTERNATIONAL | 2004年 / 17卷 / 12期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：14 / +

页数：2

相关论文

共 7 条

[1] Approaches for Flexible Manufacturing Facilities in Vaccine Production
Nelson, Kim L.
BIOPHARM INTERNATIONAL, 2011, : 22 - +
[2] Vaccine Update: Recent Progress With Novel Vaccines, and New Approaches to Safety Monitoring and Vaccine Shortage
Ndaya-Oloo, Paul
Pitisuttithum, Punnee
Tornieporth, Nadia G.
Desgrandchamps, Daniel
Munoz, Flor M.
Kochhar, Sonali
Buttery, Jim
Bauwens, Jorgen
Bonhoeffer, Jan
JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (10): : S123 - S139
[3] Vaccine manufacturing gets boost from tobacco plants: Canada-based medicago opens U.S. Facility to exploit its influenza vaccine production method
Potera, Carol
Genetic Engineering and Biotechnology News, 2012, 32 (06): : 8 - 10
[4] Scientific and Regulatory Lessons Learnt on Building a Chemistry, Manufacturing, and Controls (CMC) Package for COVID-19 Variant Vaccine Updates in the EU-A Regulator's Perspective
Shivji, Ragini
Grabski, Elena
Jekerle, Veronika
VACCINES, 2024, 12 (11)
[5] Immununogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5 year olds in New Zealand, !Oster P, !O'Hallahan J, !Aaberge I, !Tilman S, !Ypma E, !Martin D.: Vaccine 2007;25(16):3075-9
Lennon, Diana
VACCINE, 2007, 25 (39-40) : 6835 - 6835
[6] Scientific consultation on the safety and containment of new poliovirus strains for vaccine production, clinical/regulatory testing and research. Report of a meeting held at NIBSC, Potters Bar, Hertfordshire, UK, 6/7th July 2016
Minor, Philip D.
Lane, Blanche
Mimms, South
Bar, Potters
BIOLOGICALS, 2017, 48 : 92 - 100
[7] Response to the letter written by Professor Lennon (dated April 27, 2007) regarding our publication:: "Inununogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5-year olds in New Zealand" by !Oster P, !O'Hallahan J, !Aaberge I, !Tilman S, !Ypma E, !Martin D (Vaccine 2007;25(16):3075-79)
Oster, P.
O'Hallahan, J.
Aaberge, I.
Tilman, S.
Ypma, E.
Martin, D.
VACCINE, 2007, 25 (39-40) : 6835 - 6836